T
Tempest Therapeutics (TPST)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Tempest Therapeutics (TPST)
Tempest Therapeutics, Inc. (Tempest) is a clinical-stage oncology company. The Company is focused on developing small molecules that combine both tumor-targeted and immune-mediated mechanisms with the potential to treat a range of tumors. The Company... Read more
- USD7.69
- USD8.15
- USD7.56
- USD49.27
- -29.00%
- --
- 161.12k
- 87.34k
- 26M
- 5.35
- -82.00%
Stock News
yesterday
Whirlpool says it’s a ‘winner’ under new tariffs, as consumers stay cautious
MarketWatch
yesterday
GE Vernova CEO says current U.S. demand for electricity is the largest since the end of WWII
CNBC
yesterday
Alaska Airlines warns of slower demand as second-quarter profit outlook falls short
CNBC
yesterday
Brookline: Q1 Earnings Snapshot
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
